Robert J. Pelham
0009-0005-8255-0552
Kinnate Biopharma, Inc.
1 paper found
Refreshing results…
The Irreversible FGFR Inhibitor KIN-3248 Overcomes FGFR2 Kinase Domain Mutations
Missing publications? Search for publications with a matching author name.